Source: https://www.law.cornell.edu/cfr/text/21/200.200
Timestamp: 2016-07-25 08:34:41
Document Index: 227105622

Matched Legal Cases: ['art 200', '§ 200', '§ 201', '§ 201', '§ 321', '§ 331', '§ 351', '§ 352', '§ 353', '§ 355', '§ 358', '§ 360', '§ 371', '§ 374', '§ 375']

21 CFR 200.200 - Prescription drugs; reminder advertisements and reminder labeling to provide price information to consumers. | US Law | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter C › Part 200 › Subpart E › Section 200.200 21 CFR 200.200 - Prescription drugs; reminder advertisements and reminder labeling to provide price information to consumers.
§ 200.200 Prescription drugs; reminder advertisements and reminder labeling to provide price information to consumers.
(a) Prescription drug reminder advertisements and reminder labeling intended to provide price information to consumers are exempt from the requirements of §§ 201 .100 and 202.1 of this chapter if all of the following conditions are met:
(b) This exemption from §§ 201.100 and 202.1 of this chapter is applicable to all prescription drug reminder labeling and reminder advertisements solely intended to provide consumers with information regarding the price charged for prescriptions including price lists, catalogs, and other promotional material, whether mailed, posted in a pharmacy, placed in a newspaper, or aired on radio or television.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.United States CodeU.S. Code: Title 21 - FOOD AND DRUGS§ 321 - Definitions; generally§ 331 - Prohibited acts§ 351 - Adulterated drugs and devices§ 352 - Misbranded drugs and devices§ 353 - Exemptions and consideration for certain drugs, devices, and biological products§ 355 - New drugs§ 358 - Authority to designate official names§ 360e - Premarket approval§ 371 - Regulations and hearings§ 374 - Inspection§ 375 - Publicity